Table 3. pRNFL thickness and segmented macular layer volume loss for 0–6 months after the initial ON attack.
| AQP4-Ab-positive ON-HC | AQP4-Ab-negative ON-HC | |
|---|---|---|
| pRNFL thickness (μm) | ||
| 0–2 months | -27.61μm,-25.64% | -14.47µm,-13.4% |
| 2–4 months | -28.71μm,-26.95% | -28.67μm,-26.91% |
| 4–6 months | -40.71μm,-37.80% | -36.06μm,-32.98% |
| ≥6 months | -57.91μm,-54.86% | -47.19μm,-44.70% |
| GCIP volume(mm3) | ||
| 0–2 months | -0.541mm3,-26.24% | -0.478mm3,-23.18% |
| 2–4 months | -0.637 mm3,-30.67% | -0.550 mm3,-26.46% |
| 4–6 months | -0.612mm3,-29.00% | -0.538mm3,-25.50% |
| ≥6 month | -0.810 mm3,-39.05% | -0.731 mm3,-35.25% |
| INL volume(mm3) | ||
| 0–2 months | +0.007mm3,-26.24% | +0.010mm3,+0.95% |
| 2–4 months | +0.013 mm3,+1.22% | +0.060mm3,+5.62% |
| 4–6 months | +0.029mm3,+2.78% | +0.057mm3,+5.45% |
| ≥6 month | +0087 mm3,+8.37% | +0.040 mm3,+3.85% |